Stay updated on Zolbetuximab Combo in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Zolbetuximab Combo in Gastric Cancer Clinical Trial page.

Latest updates to the Zolbetuximab Combo in Gastric Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page footer revision has been updated from v3.5.2 to v3.5.3, indicating a minor update to the ClinicalTrials.gov page version.SummaryDifference0.0%

- Check19 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe location entry changes from Padua, Italy, 35128 to Padova, Italy, 35128. It's a localization adjustment of a single site name.SummaryDifference0.0%

- Check48 days agoChange DetectedAdded revision labeled v3.5.0 and removed revision v3.4.3.SummaryDifference0.0%

- Check62 days agoChange DetectedRevision label updated to v3.4.3; the previous label v3.4.2 was removed.SummaryDifference0.0%

- Check84 days agoChange DetectedAdded metadata updates including a new 'Gastric cancer' tag and a reference to the Genetic and Rare Diseases Information Center, plus a new revision (v3.4.2). No substantive changes to study design, eligibility, or outcomes; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Zolbetuximab Combo in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Zolbetuximab Combo in Gastric Cancer Clinical Trial page.